Difficulty: Medium
Average Score: 74%
Practice
Combined chemotherapy of tuberculosis is used to:
Correct answer
A
Rationale
In the treatment of tuberculosis, a combined chemotherapy approach is utilized to decrease mycobacterium drug-resistance. This is because using multiple drugs with different mechanisms of action helps prevent the development of resistance by targeting the bacteria in different ways. Option A is correct because combining drugs decreases the likelihood of the mycobacterium becoming resistant to any single drug.
Option B is incorrect because combining drugs is aimed at preventing an increase in drug-resistance, not promoting it. Option C is incorrect because combining chemotherapy is intended to enhance antimicrobial activity, not decrease it. Option D is incorrect as combining drugs does not affect the onset of biotransformation of antimycobacterial drugs.
Educationally, understanding the rationale behind combined chemotherapy in tuberculosis treatment is crucial for healthcare professionals to make informed decisions in patient care. It highlights the importance of using a multi-drug approach to combat the development of resistance and improve treatment outcomes. By grasping this concept, healthcare providers can optimize therapy and contribute to better patient outcomes in the management of tuberculosis.
Option B is incorrect because combining drugs is aimed at preventing an increase in drug-resistance, not promoting it. Option C is incorrect because combining chemotherapy is intended to enhance antimicrobial activity, not decrease it. Option D is incorrect as combining drugs does not affect the onset of biotransformation of antimycobacterial drugs.
Educationally, understanding the rationale behind combined chemotherapy in tuberculosis treatment is crucial for healthcare professionals to make informed decisions in patient care. It highlights the importance of using a multi-drug approach to combat the development of resistance and improve treatment outcomes. By grasping this concept, healthcare providers can optimize therapy and contribute to better patient outcomes in the management of tuberculosis.